stockrow
Friday 6 November 2026
Export EWTX’s income statement to Excel — free account
Edgewise Therapeutics, Inc.
EWTX Healthcare Biotechnology
- EPS
- +2,846.5%
- Free cash flow
- −30.2%
Quarter to September 2026, against a year earlier
44.89
6.02
+15.49%
Follow EWTX
Alert me
Edgewise Therapeutics, Inc. (EWTX) Current ratio
Edgewise Therapeutics, Inc.'s current ratio at the end of the quarter to 30 September 2026 was 12.3×, down 7.6× from fiscal 2025 (19.9×). Over the past ten years it has ranged from 19.5× (fiscal 2023) to 29.9× (fiscal 2020); the current reading is higher than 33% of that period. That is above the Biotechnology industry median of 4.9× and above the Healthcare sector median of 3.1×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2025 | 19.9× | (0.37%) |
| FY2024 | 19.9× | 2.21% |
| FY2023 | 19.5× | (9.42%) |
| FY2022 | 21.5× | (20.19%) |
| FY2021 | 27.0× | (9.67%) |
| FY2020 | 29.9× | — |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Sep 2026 | 12.3× | (24.24%) |
| Jun 2026 | 16.2× | (28.21%) |
| Mar 2026 | 22.6× | 13.91% |
| Dec 2025 | 19.9× | (25.12%) |
| 20 more quarters | Free account |
Against its own ten years
Low 19.5×
High 29.9×
Ten-year median
20.7×
Current reading's percentile
33
Current ratio against peers
| Company | Current ratio |
|---|---|
| TNGX Tango Therapeutics, Inc. compare | 50.8× |
| XENE Xenon Pharmaceuticals Inc. compare | 21.0× |
| RLAY Relay Therapeutics, Inc. compare | 18.3× |
| EWTX Edgewise Therapeutics, Inc. | 16.2× |
| ABCL AbCellera Biologics Inc. compare | 12.8× |
| DFTX Definium Therapeutics, Inc. compare | 6.9× |
| IOVA Iovance Biotherapeutics, Inc. compare | 5.2× |
| LEGN Legend Biotech Corporation Sponsored ADR compare | 3.0× |
| ARQT Arcutis Biotherapeutics, Inc. compare | 2.9× |
| Biotechnology industry median | 4.9× |
| Healthcare sector median | 3.1× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)